San Francisco - The FDA has its eye on New-Fill (Dermik Laboratories), a polylactic acid filler that experts predict could become a popular treatment for moderate to deep wrinkles and volume loss.
Derm In The News: September 17-23
The Cutaneous Connection: Exploring the Effects of Pollutants on Atopic Dermatitis
CeraVe Partners With George Washington University to Expand Residency Training Program
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Combination Treatments in HS Require Further Review
Frontline Forum Part 4: Improving Basal Cell Carcinoma Management